doi: 10.3389/fmed.2026.1755596 Received 27 November 2025 Revised 04 July 2026 Accepted 07 July 2026 Published 24 July 2026 Volume 13 - 2026 Edited by Kok Lun Pang, Monash University Malaysia, Malaysia Reviewed by Kok Yong Chin, National University of Malaysia, Malaysia Chia Ying Li, National Pingtung University, Taiwan Updates Copyright 2026 Zhan, Xia and Tao
BOC Sciences optimized the separation protocol and provided us with clear data on loading efficiency and encapsulation efficiency
Patients consistently report improved cognitive clarity, sustained energy, and a return of the drive that had quietly faded
By activating the GLP-1 receptor, retatrutide is thought to enhance insulin secretion in a glucose-dependent manner, suppress glucagon release, and reduce appetite by acting on satiety centres in the brain
It is not an injectable protocol
22 : 857871 Hibbeln JR, Palmer JW, Davis JM